MicroRNA-155 Plays Selective Cell-Intrinsic Roles in Brain-Infiltrating Immune Cell Populations during Neuroinflammation
The Journal of Immunology · 2023
DOI: 10.4049/jimmunol.2200478 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Jacob W Thompson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis, MicroRNAs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
The proinflammatory microRNA-155 (miR-155) is highly expressed in the serum and CNS lesions of patients with multiple sclerosis (MS). Global knockout (KO) of miR-155 in mice confers resistance to a mouse model of MS, experimental autoimmune encephalomyelitis (EAE), by reducing the encephalogenic potential of CNS-infiltrating Th17 T cells. However, cell-intrinsic roles for miR-155 during EAE have not been formally determined. In this study, we use single-cell RNA sequencing and cell-specific conditional miR-155 KOs to determine the importance of miR-155 expression in distinct immune cell populations. Time-course single-cell sequencing revealed reductions in T cells, macrophages, and dendritic cells (DCs) in global miR-155 KO mice compared with wild-type controls at day 21 after EAE induction. Deletion of miR-155 in T cells, driven by CD4 Cre, significantly reduced disease severity similar to global miR-155 KOs. CD11c Cre-mediated deletion of miR-155 in DCs also resulted in a modest yet significant reduction in the development of EAE, with both T cell– and DC-specific KOs showing a reduction in Th17 T cell infiltration into the CNS. Although miR-155 is highly expressed in infiltrating macrophages during EAE, deletion of miR-155 using LysM Cre did not impact disease severity. Taken together, these data show that although miR-155 is highly expressed in most infiltrating immune cells, miR-155 has distinct roles and requirements depending on the cell type, and we have demonstrated this using the gold standard conditional KO approach. This provides insights into which functionally relevant cell types should be targeted by the next generation of miRNA therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Division of Microbiology and Immunology, University of Utah, Salt Lake City, UT.
- Izmir Institute of Technology, The Department of Molecular Biology and Genetics Gulbahce, Urla, Izmir.
- Hunstman Cancer Institute, University of Utah, Salt Lake City, UT.
ORCID-Profile: Jacob W Thompson, Kaylyn M Bauer
Förderung
- NCI NIH HHS
- NIA NIH HHS
- NINDS NIH HHS
- National Multiple Sclerosis Society
- HHS | NIH | National Institute of Neurological Disorders and Stroke
Zitieren
APA
Thompson, J. W., Hu, R., Huffaker, T. B., Ramstead, A. G., Ekiz, H. A., Bauer, K. M., Tang, W. W., Ghazaryan, A., Round, J. L., Fujinami, R. S., & O'Connell, R. M. (2023). MicroRNA-155 Plays Selective Cell-Intrinsic Roles in Brain-Infiltrating Immune Cell Populations during Neuroinflammation. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200478
Vancouver
Thompson JW, Hu R, Huffaker TB, Ramstead AG, Ekiz HA, Bauer KM, et al. MicroRNA-155 Plays Selective Cell-Intrinsic Roles in Brain-Infiltrating Immune Cell Populations during Neuroinflammation. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200478
BibTeX
@article{Thompson2023,
author = {Thompson, Jacob W and Hu, Ruozhen and Huffaker, Thomas B and Ramstead, Andrew G and Ekiz, H Atakan and Bauer, Kaylyn M and Tang, William W and Ghazaryan, Arevik and Round, June L and Fujinami, Robert S and O'Connell, Ryan M},
title = {MicroRNA-155 Plays Selective Cell-Intrinsic Roles in Brain-Infiltrating Immune Cell Populations during Neuroinflammation},
journal = {The Journal of Immunology},
year = {2023},
doi = {10.4049/jimmunol.2200478}
}
EUVIMED